nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—ACHE—Irinotecan—pancreatic cancer	0.39	0.476	CbGbCtD
Pyridostigmine—BCHE—Irinotecan—pancreatic cancer	0.235	0.287	CbGbCtD
Pyridostigmine—CYP3A4—Tamoxifen—pancreatic cancer	0.0465	0.0568	CbGbCtD
Pyridostigmine—CYP3A4—Erlotinib—pancreatic cancer	0.0396	0.0483	CbGbCtD
Pyridostigmine—CYP3A4—Irinotecan—pancreatic cancer	0.0357	0.0436	CbGbCtD
Pyridostigmine—CYP3A4—Docetaxel—pancreatic cancer	0.0262	0.032	CbGbCtD
Pyridostigmine—CYP3A4—Sunitinib—pancreatic cancer	0.0261	0.0318	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—pancreatic cancer	0.0195	0.0238	CbGbCtD
Pyridostigmine—Lacrimation increased—Fluorouracil—pancreatic cancer	0.00163	0.009	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Irinotecan—pancreatic cancer	0.00153	0.00841	CcSEcCtD
Pyridostigmine—Dry skin—Erlotinib—pancreatic cancer	0.00147	0.00808	CcSEcCtD
Pyridostigmine—Cramp muscle—Tamoxifen—pancreatic cancer	0.00146	0.00802	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Gemcitabine—pancreatic cancer	0.00136	0.00751	CcSEcCtD
Pyridostigmine—Bronchitis—Tamoxifen—pancreatic cancer	0.00134	0.00741	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Irinotecan—pancreatic cancer	0.00132	0.00726	CcSEcCtD
Pyridostigmine—Dry skin—Sunitinib—pancreatic cancer	0.00127	0.007	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Fluorouracil—pancreatic cancer	0.00126	0.00696	CcSEcCtD
Pyridostigmine—Lacrimation—Epirubicin—pancreatic cancer	0.00125	0.00687	CcSEcCtD
Pyridostigmine—Chest discomfort—Docetaxel—pancreatic cancer	0.00123	0.00677	CcSEcCtD
Pyridostigmine—Abdominal distension—Sunitinib—pancreatic cancer	0.0012	0.00664	CcSEcCtD
Pyridostigmine—Lacrimation increased—Docetaxel—pancreatic cancer	0.00118	0.0065	CcSEcCtD
Pyridostigmine—Epistaxis—Erlotinib—pancreatic cancer	0.00116	0.00641	CcSEcCtD
Pyridostigmine—Lacrimation—Doxorubicin—pancreatic cancer	0.00115	0.00635	CcSEcCtD
Pyridostigmine—Bronchitis—Sunitinib—pancreatic cancer	0.00115	0.00634	CcSEcCtD
Pyridostigmine—Lethargy—Fluorouracil—pancreatic cancer	0.00111	0.00614	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.00111	0.00613	CcSEcCtD
Pyridostigmine—Blood pressure increased—Docetaxel—pancreatic cancer	0.00109	0.00599	CcSEcCtD
Pyridostigmine—Cardiac arrest—Irinotecan—pancreatic cancer	0.00108	0.00598	CcSEcCtD
Pyridostigmine—Cardiac arrest—Fluorouracil—pancreatic cancer	0.00104	0.00573	CcSEcCtD
Pyridostigmine—Cramp muscle—Irinotecan—pancreatic cancer	0.00103	0.00566	CcSEcCtD
Pyridostigmine—Epistaxis—Sunitinib—pancreatic cancer	0.00101	0.00555	CcSEcCtD
Pyridostigmine—Dry skin—Fluorouracil—pancreatic cancer	0.001	0.00552	CcSEcCtD
Pyridostigmine—Abdominal distension—Irinotecan—pancreatic cancer	0.000992	0.00547	CcSEcCtD
Pyridostigmine—Alopecia—Tamoxifen—pancreatic cancer	0.000988	0.00545	CcSEcCtD
Pyridostigmine—Alopecia—Erlotinib—pancreatic cancer	0.000977	0.00539	CcSEcCtD
Pyridostigmine—Bradycardia—Sunitinib—pancreatic cancer	0.000975	0.00538	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Docetaxel—pancreatic cancer	0.000966	0.00533	CcSEcCtD
Pyridostigmine—Sweating increased—Irinotecan—pancreatic cancer	0.00096	0.00529	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Sunitinib—pancreatic cancer	0.000953	0.00525	CcSEcCtD
Pyridostigmine—Flatulence—Erlotinib—pancreatic cancer	0.000949	0.00523	CcSEcCtD
Pyridostigmine—Amblyopia—Epirubicin—pancreatic cancer	0.000948	0.00523	CcSEcCtD
Pyridostigmine—Muscle spasms—Tamoxifen—pancreatic cancer	0.000936	0.00516	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Docetaxel—pancreatic cancer	0.00091	0.00502	CcSEcCtD
Pyridostigmine—Amblyopia—Doxorubicin—pancreatic cancer	0.000877	0.00484	CcSEcCtD
Pyridostigmine—Loss of consciousness—Erlotinib—pancreatic cancer	0.000846	0.00467	CcSEcCtD
Pyridostigmine—Alopecia—Sunitinib—pancreatic cancer	0.000846	0.00467	CcSEcCtD
Pyridostigmine—Myalgia—Tamoxifen—pancreatic cancer	0.000828	0.00457	CcSEcCtD
Pyridostigmine—Flatulence—Sunitinib—pancreatic cancer	0.000821	0.00453	CcSEcCtD
Pyridostigmine—Myalgia—Erlotinib—pancreatic cancer	0.00082	0.00452	CcSEcCtD
Pyridostigmine—Lethargy—Docetaxel—pancreatic cancer	0.000804	0.00444	CcSEcCtD
Pyridostigmine—Bradycardia—Irinotecan—pancreatic cancer	0.000803	0.00443	CcSEcCtD
Pyridostigmine—Muscle spasms—Sunitinib—pancreatic cancer	0.000801	0.00442	CcSEcCtD
Pyridostigmine—Lacrimation increased—Epirubicin—pancreatic cancer	0.000795	0.00438	CcSEcCtD
Pyridostigmine—Epistaxis—Fluorouracil—pancreatic cancer	0.000794	0.00438	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000768	0.00423	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000752	0.00414	CcSEcCtD
Pyridostigmine—Neck pain—Epirubicin—pancreatic cancer	0.000741	0.00409	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—pancreatic cancer	0.000735	0.00405	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000724	0.00399	CcSEcCtD
Pyridostigmine—Dry skin—Docetaxel—pancreatic cancer	0.000722	0.00398	CcSEcCtD
Pyridostigmine—Convulsion—Sunitinib—pancreatic cancer	0.000722	0.00398	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.000716	0.00395	CcSEcCtD
Pyridostigmine—Paraesthesia—Tamoxifen—pancreatic cancer	0.000713	0.00393	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Epirubicin—pancreatic cancer	0.000711	0.00392	CcSEcCtD
Pyridostigmine—Cramp muscle—Docetaxel—pancreatic cancer	0.00071	0.00391	CcSEcCtD
Pyridostigmine—Myalgia—Sunitinib—pancreatic cancer	0.00071	0.00391	CcSEcCtD
Pyridostigmine—Alopecia—Irinotecan—pancreatic cancer	0.000697	0.00384	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—pancreatic cancer	0.000686	0.00378	CcSEcCtD
Pyridostigmine—Alopecia—Gemcitabine—pancreatic cancer	0.000679	0.00374	CcSEcCtD
Pyridostigmine—Flatulence—Irinotecan—pancreatic cancer	0.000676	0.00373	CcSEcCtD
Pyridostigmine—Alopecia—Fluorouracil—pancreatic cancer	0.000667	0.00368	CcSEcCtD
Pyridostigmine—Muscle spasms—Irinotecan—pancreatic cancer	0.00066	0.00364	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—pancreatic cancer	0.000658	0.00363	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.000652	0.00359	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000649	0.00358	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000643	0.00354	CcSEcCtD
Pyridostigmine—Hypertonia—Epirubicin—pancreatic cancer	0.000642	0.00354	CcSEcCtD
Pyridostigmine—Urticaria—Tamoxifen—pancreatic cancer	0.000631	0.00348	CcSEcCtD
Pyridostigmine—Abdominal pain—Tamoxifen—pancreatic cancer	0.000628	0.00346	CcSEcCtD
Pyridostigmine—Abdominal pain—Erlotinib—pancreatic cancer	0.000621	0.00343	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00062	0.00342	CcSEcCtD
Pyridostigmine—Vertigo—Irinotecan—pancreatic cancer	0.000617	0.0034	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Epirubicin—pancreatic cancer	0.000614	0.00339	CcSEcCtD
Pyridostigmine—Paraesthesia—Sunitinib—pancreatic cancer	0.000611	0.00337	CcSEcCtD
Pyridostigmine—Loss of consciousness—Irinotecan—pancreatic cancer	0.000603	0.00333	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.000603	0.00333	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—pancreatic cancer	0.000594	0.00328	CcSEcCtD
Pyridostigmine—Eye pain—Epirubicin—pancreatic cancer	0.000589	0.00325	CcSEcCtD
Pyridostigmine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000585	0.00323	CcSEcCtD
Pyridostigmine—Epistaxis—Docetaxel—pancreatic cancer	0.000573	0.00316	CcSEcCtD
Pyridostigmine—Asthenia—Tamoxifen—pancreatic cancer	0.00057	0.00314	CcSEcCtD
Pyridostigmine—Convulsion—Fluorouracil—pancreatic cancer	0.00057	0.00314	CcSEcCtD
Pyridostigmine—Myalgia—Gemcitabine—pancreatic cancer	0.000569	0.00314	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—pancreatic cancer	0.000568	0.00313	CcSEcCtD
Pyridostigmine—Confusional state—Irinotecan—pancreatic cancer	0.000565	0.00312	CcSEcCtD
Pyridostigmine—Asthenia—Erlotinib—pancreatic cancer	0.000564	0.00311	CcSEcCtD
Pyridostigmine—Myalgia—Fluorouracil—pancreatic cancer	0.00056	0.00309	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000556	0.00307	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—pancreatic cancer	0.000545	0.003	CcSEcCtD
Pyridostigmine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000543	0.003	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000542	0.00299	CcSEcCtD
Pyridostigmine—Lethargy—Epirubicin—pancreatic cancer	0.000542	0.00299	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000542	0.00299	CcSEcCtD
Pyridostigmine—Confusional state—Fluorouracil—pancreatic cancer	0.000541	0.00298	CcSEcCtD
Pyridostigmine—Abdominal pain—Sunitinib—pancreatic cancer	0.000538	0.00297	CcSEcCtD
Pyridostigmine—Diarrhoea—Erlotinib—pancreatic cancer	0.000538	0.00297	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000528	0.00291	CcSEcCtD
Pyridostigmine—Hypotension—Irinotecan—pancreatic cancer	0.000524	0.00289	CcSEcCtD
Pyridostigmine—Hypotension—Gemcitabine—pancreatic cancer	0.00051	0.00281	CcSEcCtD
Pyridostigmine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000505	0.00279	CcSEcCtD
Pyridostigmine—Vomiting—Tamoxifen—pancreatic cancer	0.000505	0.00278	CcSEcCtD
Pyridostigmine—Paraesthesia—Irinotecan—pancreatic cancer	0.000503	0.00277	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—pancreatic cancer	0.000502	0.00277	CcSEcCtD
Pyridostigmine—Hypotension—Fluorouracil—pancreatic cancer	0.000501	0.00277	CcSEcCtD
Pyridostigmine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000501	0.00276	CcSEcCtD
Pyridostigmine—Rash—Tamoxifen—pancreatic cancer	0.000501	0.00276	CcSEcCtD
Pyridostigmine—Dermatitis—Tamoxifen—pancreatic cancer	0.0005	0.00276	CcSEcCtD
Pyridostigmine—Vomiting—Erlotinib—pancreatic cancer	0.0005	0.00276	CcSEcCtD
Pyridostigmine—Somnolence—Irinotecan—pancreatic cancer	0.000498	0.00275	CcSEcCtD
Pyridostigmine—Headache—Tamoxifen—pancreatic cancer	0.000498	0.00274	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000497	0.00274	CcSEcCtD
Pyridostigmine—Rash—Erlotinib—pancreatic cancer	0.000495	0.00273	CcSEcCtD
Pyridostigmine—Dermatitis—Erlotinib—pancreatic cancer	0.000495	0.00273	CcSEcCtD
Pyridostigmine—Headache—Erlotinib—pancreatic cancer	0.000492	0.00271	CcSEcCtD
Pyridostigmine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00049	0.0027	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000489	0.0027	CcSEcCtD
Pyridostigmine—Asthenia—Sunitinib—pancreatic cancer	0.000488	0.00269	CcSEcCtD
Pyridostigmine—Dry skin—Epirubicin—pancreatic cancer	0.000487	0.00269	CcSEcCtD
Pyridostigmine—Somnolence—Gemcitabine—pancreatic cancer	0.000485	0.00268	CcSEcCtD
Pyridostigmine—Paraesthesia—Fluorouracil—pancreatic cancer	0.000482	0.00266	CcSEcCtD
Pyridostigmine—Alopecia—Docetaxel—pancreatic cancer	0.000482	0.00266	CcSEcCtD
Pyridostigmine—Somnolence—Fluorouracil—pancreatic cancer	0.000477	0.00263	CcSEcCtD
Pyridostigmine—Nausea—Tamoxifen—pancreatic cancer	0.000472	0.0026	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000468	0.00258	CcSEcCtD
Pyridostigmine—Nausea—Erlotinib—pancreatic cancer	0.000467	0.00257	CcSEcCtD
Pyridostigmine—Diarrhoea—Sunitinib—pancreatic cancer	0.000465	0.00257	CcSEcCtD
Pyridostigmine—Abdominal distension—Epirubicin—pancreatic cancer	0.000462	0.00255	CcSEcCtD
Pyridostigmine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000462	0.00255	CcSEcCtD
Pyridostigmine—Asthma—Epirubicin—pancreatic cancer	0.000459	0.00253	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000458	0.00253	CcSEcCtD
Pyridostigmine—Muscle spasms—Docetaxel—pancreatic cancer	0.000456	0.00252	CcSEcCtD
Pyridostigmine—Dry skin—Doxorubicin—pancreatic cancer	0.000451	0.00249	CcSEcCtD
Pyridostigmine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00045	0.00248	CcSEcCtD
Pyridostigmine—Abdominal pain—Irinotecan—pancreatic cancer	0.000443	0.00244	CcSEcCtD
Pyridostigmine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000442	0.00244	CcSEcCtD
Pyridostigmine—Bronchitis—Epirubicin—pancreatic cancer	0.000442	0.00244	CcSEcCtD
Pyridostigmine—Vomiting—Sunitinib—pancreatic cancer	0.000432	0.00239	CcSEcCtD
Pyridostigmine—Rash—Sunitinib—pancreatic cancer	0.000429	0.00237	CcSEcCtD
Pyridostigmine—Dermatitis—Sunitinib—pancreatic cancer	0.000428	0.00236	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—pancreatic cancer	0.000428	0.00236	CcSEcCtD
Pyridostigmine—Urticaria—Fluorouracil—pancreatic cancer	0.000426	0.00235	CcSEcCtD
Pyridostigmine—Headache—Sunitinib—pancreatic cancer	0.000426	0.00235	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—pancreatic cancer	0.000425	0.00234	CcSEcCtD
Pyridostigmine—Pollakiuria—Epirubicin—pancreatic cancer	0.000424	0.00234	CcSEcCtD
Pyridostigmine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000417	0.0023	CcSEcCtD
Pyridostigmine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000413	0.00228	CcSEcCtD
Pyridostigmine—Convulsion—Docetaxel—pancreatic cancer	0.000411	0.00227	CcSEcCtD
Pyridostigmine—Drowsiness—Epirubicin—pancreatic cancer	0.00041	0.00226	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—pancreatic cancer	0.000409	0.00225	CcSEcCtD
Pyridostigmine—Myalgia—Docetaxel—pancreatic cancer	0.000404	0.00223	CcSEcCtD
Pyridostigmine—Nausea—Sunitinib—pancreatic cancer	0.000404	0.00223	CcSEcCtD
Pyridostigmine—Asthenia—Irinotecan—pancreatic cancer	0.000402	0.00222	CcSEcCtD
Pyridostigmine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000395	0.00218	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000393	0.00217	CcSEcCtD
Pyridostigmine—Asthenia—Gemcitabine—pancreatic cancer	0.000392	0.00216	CcSEcCtD
Pyridostigmine—Confusional state—Docetaxel—pancreatic cancer	0.000391	0.00215	CcSEcCtD
Pyridostigmine—Epistaxis—Epirubicin—pancreatic cancer	0.000386	0.00213	CcSEcCtD
Pyridostigmine—Diarrhoea—Irinotecan—pancreatic cancer	0.000383	0.00211	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—pancreatic cancer	0.000379	0.00209	CcSEcCtD
Pyridostigmine—Bradycardia—Epirubicin—pancreatic cancer	0.000374	0.00206	CcSEcCtD
Pyridostigmine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000373	0.00206	CcSEcCtD
Pyridostigmine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000367	0.00202	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000366	0.00202	CcSEcCtD
Pyridostigmine—Hypotension—Docetaxel—pancreatic cancer	0.000362	0.002	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—pancreatic cancer	0.000357	0.00197	CcSEcCtD
Pyridostigmine—Vomiting—Irinotecan—pancreatic cancer	0.000356	0.00196	CcSEcCtD
Pyridostigmine—Rash—Irinotecan—pancreatic cancer	0.000353	0.00195	CcSEcCtD
Pyridostigmine—Dermatitis—Irinotecan—pancreatic cancer	0.000353	0.00195	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000353	0.00195	CcSEcCtD
Pyridostigmine—Headache—Irinotecan—pancreatic cancer	0.000351	0.00194	CcSEcCtD
Pyridostigmine—Paraesthesia—Docetaxel—pancreatic cancer	0.000348	0.00192	CcSEcCtD
Pyridostigmine—Vomiting—Gemcitabine—pancreatic cancer	0.000347	0.00191	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—pancreatic cancer	0.000346	0.00191	CcSEcCtD
Pyridostigmine—Somnolence—Docetaxel—pancreatic cancer	0.000344	0.0019	CcSEcCtD
Pyridostigmine—Rash—Gemcitabine—pancreatic cancer	0.000344	0.0019	CcSEcCtD
Pyridostigmine—Dermatitis—Gemcitabine—pancreatic cancer	0.000344	0.0019	CcSEcCtD
Pyridostigmine—Headache—Gemcitabine—pancreatic cancer	0.000342	0.00189	CcSEcCtD
Pyridostigmine—Vomiting—Fluorouracil—pancreatic cancer	0.000341	0.00188	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000339	0.00187	CcSEcCtD
Pyridostigmine—Rash—Fluorouracil—pancreatic cancer	0.000338	0.00187	CcSEcCtD
Pyridostigmine—Dermatitis—Fluorouracil—pancreatic cancer	0.000338	0.00186	CcSEcCtD
Pyridostigmine—Headache—Fluorouracil—pancreatic cancer	0.000336	0.00185	CcSEcCtD
Pyridostigmine—Nausea—Irinotecan—pancreatic cancer	0.000333	0.00184	CcSEcCtD
Pyridostigmine—Alopecia—Epirubicin—pancreatic cancer	0.000325	0.00179	CcSEcCtD
Pyridostigmine—Nausea—Gemcitabine—pancreatic cancer	0.000324	0.00179	CcSEcCtD
Pyridostigmine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000319	0.00176	CcSEcCtD
Pyridostigmine—Nausea—Fluorouracil—pancreatic cancer	0.000319	0.00176	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000317	0.00175	CcSEcCtD
Pyridostigmine—Flatulence—Epirubicin—pancreatic cancer	0.000315	0.00174	CcSEcCtD
Pyridostigmine—Muscle spasms—Epirubicin—pancreatic cancer	0.000308	0.0017	CcSEcCtD
Pyridostigmine—Abdominal pain—Docetaxel—pancreatic cancer	0.000306	0.00169	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—pancreatic cancer	0.000301	0.00166	CcSEcCtD
Pyridostigmine—Agitation—Epirubicin—pancreatic cancer	0.000294	0.00162	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—pancreatic cancer	0.000292	0.00161	CcSEcCtD
Pyridostigmine—Vertigo—Epirubicin—pancreatic cancer	0.000288	0.00159	CcSEcCtD
Pyridostigmine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000285	0.00157	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000285	0.00157	CcSEcCtD
Pyridostigmine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000281	0.00155	CcSEcCtD
Pyridostigmine—Asthenia—Docetaxel—pancreatic cancer	0.000278	0.00153	CcSEcCtD
Pyridostigmine—Convulsion—Epirubicin—pancreatic cancer	0.000277	0.00153	CcSEcCtD
Pyridostigmine—Myalgia—Epirubicin—pancreatic cancer	0.000273	0.0015	CcSEcCtD
Pyridostigmine—Agitation—Doxorubicin—pancreatic cancer	0.000272	0.0015	CcSEcCtD
Pyridostigmine—Vertigo—Doxorubicin—pancreatic cancer	0.000266	0.00147	CcSEcCtD
Pyridostigmine—Diarrhoea—Docetaxel—pancreatic cancer	0.000265	0.00146	CcSEcCtD
Pyridostigmine—Confusional state—Epirubicin—pancreatic cancer	0.000263	0.00145	CcSEcCtD
Pyridostigmine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.00026	0.00144	CcSEcCtD
Pyridostigmine—Convulsion—Doxorubicin—pancreatic cancer	0.000257	0.00142	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000253	0.00139	CcSEcCtD
Pyridostigmine—Myalgia—Doxorubicin—pancreatic cancer	0.000252	0.00139	CcSEcCtD
Pyridostigmine—Vomiting—Docetaxel—pancreatic cancer	0.000246	0.00136	CcSEcCtD
Pyridostigmine—Rash—Docetaxel—pancreatic cancer	0.000244	0.00135	CcSEcCtD
Pyridostigmine—Hypotension—Epirubicin—pancreatic cancer	0.000244	0.00135	CcSEcCtD
Pyridostigmine—Dermatitis—Docetaxel—pancreatic cancer	0.000244	0.00135	CcSEcCtD
Pyridostigmine—Confusional state—Doxorubicin—pancreatic cancer	0.000244	0.00134	CcSEcCtD
Pyridostigmine—Headache—Docetaxel—pancreatic cancer	0.000243	0.00134	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000238	0.00131	CcSEcCtD
Pyridostigmine—Paraesthesia—Epirubicin—pancreatic cancer	0.000235	0.00129	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000234	0.00129	CcSEcCtD
Pyridostigmine—Somnolence—Epirubicin—pancreatic cancer	0.000232	0.00128	CcSEcCtD
Pyridostigmine—Nausea—Docetaxel—pancreatic cancer	0.00023	0.00127	CcSEcCtD
Pyridostigmine—Hypotension—Doxorubicin—pancreatic cancer	0.000226	0.00125	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.00022	0.00121	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000217	0.0012	CcSEcCtD
Pyridostigmine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000215	0.00119	CcSEcCtD
Pyridostigmine—Somnolence—Doxorubicin—pancreatic cancer	0.000215	0.00119	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000214	0.00118	CcSEcCtD
Pyridostigmine—Urticaria—Epirubicin—pancreatic cancer	0.000208	0.00114	CcSEcCtD
Pyridostigmine—Abdominal pain—Epirubicin—pancreatic cancer	0.000207	0.00114	CcSEcCtD
Pyridostigmine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000199	0.0011	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000198	0.00109	CcSEcCtD
Pyridostigmine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000192	0.00106	CcSEcCtD
Pyridostigmine—Urticaria—Doxorubicin—pancreatic cancer	0.000192	0.00106	CcSEcCtD
Pyridostigmine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000191	0.00105	CcSEcCtD
Pyridostigmine—Asthenia—Epirubicin—pancreatic cancer	0.000187	0.00103	CcSEcCtD
Pyridostigmine—Diarrhoea—Epirubicin—pancreatic cancer	0.000179	0.000986	CcSEcCtD
Pyridostigmine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000178	0.000982	CcSEcCtD
Pyridostigmine—Asthenia—Doxorubicin—pancreatic cancer	0.000173	0.000957	CcSEcCtD
Pyridostigmine—Vomiting—Epirubicin—pancreatic cancer	0.000166	0.000916	CcSEcCtD
Pyridostigmine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000165	0.000912	CcSEcCtD
Pyridostigmine—Rash—Epirubicin—pancreatic cancer	0.000165	0.000908	CcSEcCtD
Pyridostigmine—Dermatitis—Epirubicin—pancreatic cancer	0.000165	0.000908	CcSEcCtD
Pyridostigmine—Headache—Epirubicin—pancreatic cancer	0.000164	0.000903	CcSEcCtD
Pyridostigmine—Nausea—Epirubicin—pancreatic cancer	0.000155	0.000856	CcSEcCtD
Pyridostigmine—Vomiting—Doxorubicin—pancreatic cancer	0.000154	0.000848	CcSEcCtD
Pyridostigmine—Rash—Doxorubicin—pancreatic cancer	0.000152	0.000841	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—pancreatic cancer	0.000152	0.00084	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—pancreatic cancer	0.000151	0.000835	CcSEcCtD
Pyridostigmine—Nausea—Doxorubicin—pancreatic cancer	0.000144	0.000792	CcSEcCtD
